Preeclampsia Clinical Trial
Official title:
The Correlation Between Vitamin A / E Levels and Preeclampsia.
Vitamin A (VA) and vitamin E (VE) are fat-soluble vitamins and indispensable substances in
life activities.
VA plays an important role in visual function, normal formation and development of epithelial
cells, development and growth of bones, immune function and reproductive health. VA is of
great significancCe for the growth and development of embryonic cells, especially for the
development of fetal vertebrae, spinal cord, limbs, heart, eyes and ears. The lack of
maternal VA will lead to the stunted development of fetal organs and tissues, and even fetal
developmental malformation. In addition, VA has a protective effect on neonatal lung
maturation.VA deficiency can cause the decrease in the activity of enzymes needed to catalyze
the formation of progesterone precursors in pregnant women, reduce the production of steroids
in adrenal glands, gonads and placenta, and seriously affect the functions of multiple organs
such as heart, liver and skeletal muscle in pregnant women.
VE, also known as tocopherol, has non-enzymatic antioxidant function, and maintains the
balance of REDOX reaction in vivo by efficiently removing free radicals generated by lipid
peroxidation.VE can increase the synthesis of nitric oxide (NO) in endothelial cells and
improve vascular endothelial function. Long-term administration of VE can improve the
impaired endothelium-dependent vasodilatory function in patients.VE can promote sex hormone
secretion, improve fertility and prevent abortion. Pregnancy women the body's metabolism,
increases produce free radicals, lipid peroxidation, low levels of VE will result in the
accumulation of excess free radicals, cause the placenta aging, vascular endothelial damage,
increase the risk of the occurrence of PHI and adverse outcome rate, as well as the membranes
of cell membrane damage, increase the risk of premature rupture of membranes.
Gestational hypertension is a group of diseases with both pregnancy and elevated blood
pressure, and is the main cause of increased maternal and perinatal mortality, mainly
including gestational hypertension, preeclampsia PE, and eclampsia, as well as chronic
hypertension with preeclampsia and chronic hypertension with pregnancy. The cause of PE is
unknown, but studies have found that it may be related to insufficient recast of spiral
uterine arterioles, excessive activation of inflammatory immune system, damage of vascular
endothelial cells, genetic factors, nutritional deficiency and insulin resistance. Recent
studies have found that free radical oxidative damage may also be one of the main reasons for
the occurrence and development of PE. PE occurs, the placenta bed vasospasm, ischemia,
angiogenesis blocking and endothelial atherosclerotic changes, local immune cell activity,
make produce free radicals increases, interfere with the vascular endothelial cell function,
reduce vascular relaxation material synthesis, and shrink blood vessels increase material
synthesis, promote vascular spasm, platelet condensed state is changed, thus appeared a
series of PE.
Previous studies have shown that oxygen free radicals and lipid peroxides are increased in
PHI patients, while the levels of VA and VE are closely related to the antioxidant capacity
of the body, and their lack can lead to the imbalance of the homeostasis of redox reaction in
multi-tissue cells in the body. Since both VA and VE belong to fat-soluble vitamins and are
widely distributed in daily food, whether their effects on the occurrence and development of
PE are independent or combined will be a question for us to explore. Therefore, this study
intends to evaluate the correlation between VA, VE and VA+VE and PE occurrence through
multi-center clinical studies, and explore and summarize the feasibility of VA and VE in PE
adjuvant treatment.
Vitamin A (VA) and vitamin E (VE) are fat-soluble vitamins, which participate in the
metabolism of important substances in the body and are indispensable substances in life
activities.
VA, also known as retinol, plays an important role in visual function, normal formation and
development of epithelial cells, development and growth of bones, immune function and
reproductive health. During fetal development, VA affects cell differentiation and
proliferation by regulating gene expression, which is of great significance for the growth
and development of embryonic cells, especially for the development of fetal vertebrae, spinal
cord, limbs, heart, eyes and ears. Maternal lack of VA will lead to the fetal,s organ tissue
dysplasia, even serious fetal development deformity. In addition, VA can promote the growth
of columnar epithelial cells on the surface of alveoli, and has a certain protective effect
on the maturation of neonatal lungs. VA deficiency can cause the decrease in the activity of
enzymes needed to catalyze the formation of progesterone precursors in pregnant women, reduce
the production of steroids in adrenal glands, gonads and placenta, and seriously affect the
functions of multiple organs such as heart, liver and skeletal muscle in pregnant women.
VE, also known as tocopherol, has non-enzymatic antioxidant function, and maintains the
balance of REDOX reaction in vivo by efficiently removing free radicals generated by lipid
peroxidation.VE can increase the synthesis of nitric oxide (NO) in endothelial cells, release
electrons to stabilize free radicals, protect NO from inactivation of free radicals, and
improve vascular endothelial function. Long-term use of VE has been found to improve
endothelium-dependent vasodilation in patients with impaired vasodilation.VE can promote sex
hormone secretion, improve fertility, prevent abortion, clinically commonly used VE treatment
threatened abortion and habitual abortion. Pregnancy women the body's metabolism, increases
produce free radicals, lipid peroxidation, low levels of VE will result in the accumulation
of excess free radicals, which cause the placenta aging, vascular endothelial damage,
increase the risk of the occurrence of PIH and adverse outcome rate, and cell membrane damage
of membranes, the occurrence of premature rupture of membranes increased risk.
Gestational hypertension disease is a group of disease and high blood pressure, pregnancy
rate is about 5% - 12%, serious impact on maternal and child health, is a major cause of
maternal and perinatal mortality increase, mainly including gestational hypertension,
preeclampsia preeclampsia (PE), eclampsia, and chronic hypertension complicated by
preeclampsia and chronic hypertension with pregnancy. Preeclampsia is the most common type,
including mild and severe preeclampsia, of which severe preeclampsia accounts for about 30%
to 50%.The cause of PE is unknown, but studies have found that it may be related to
insufficient recast of spiral uterine arterioles, excessive activation of inflammatory immune
system, damage of vascular endothelial cells, genetic factors, nutritional deficiency and
insulin resistance. Recent studies have found that free radical oxidative damage may also be
one of the main reasons for the occurrence and development of PE.PE occurs, the placenta bed
vasospasm, ischemia, angiogenesis blocking and endothelial atherosclerotic changes,
strengthen local immune cell activity, increase the free, free radical and lipid peroxide
interfere with the vascular endothelial cell function, make blood-vessel loose material such
as nitric oxide (NO), top ring element synthesis reduce I2, materials and shrink blood
vessels, such as endothelin (ET), thromboxane A2, such as synthetic increase, promote
vascular spasm, platelet condensed state is changed, thus appeared a series of PE.
Previous studies have shown that oxygen free radicals and lipid peroxides increase in the
body of patients with PIH, and excessive antioxidants are consumed. However, the levels of VA
and VE are closely related to the antioxidant capacity of the body, and the lack of them can
lead to the imbalance of redox reaction homeostasis in multi-tissue cells in the body, thus
resulting in the occurrence of oxidative stress in the body. Studies have found that
oxidative stress can cause the occurrence and development of PE when the levels of VA and VE
are reduced. Therefore, it is not clear whether the application of VA and VE can reduce the
incidence of PE and improve the prognosis of neonates. Since both VA and VE belong to the
family of fat-soluble vitamins and are widely present in daily food, are they independent or
combined in influencing the occurrence and development of PE. Therefore, this study intends
to evaluate the correlation between VA, VE and VA+VE in PE during pregnancy through
multi-center clinical studies, and explore and summarize the feasibility of VA and VE in PE
adjuvant treatment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03510286 -
Validation of a PrCr Dipstick Diagnostic Test in Ghana
|
||
Recruiting |
NCT03313024 -
Berlin-Brandenburg Pregnancy Cohort
|
||
Active, not recruiting |
NCT04990141 -
Molecular Screening Method for Preeclampsia (PREMOM)
|
||
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT02923206 -
Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis
|
N/A | |
Not yet recruiting |
NCT02541110 -
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
|
N/A | |
Completed |
NCT02854501 -
Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
|
||
Completed |
NCT02554604 -
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
|
||
Withdrawn |
NCT05016440 -
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
|
N/A | |
Completed |
NCT02384226 -
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
|
||
Terminated |
NCT02558023 -
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
|
Phase 3 | |
Recruiting |
NCT02247297 -
Pancreatic Stone Protein (PSP) in Pregnant Women
|
||
Recruiting |
NCT02337049 -
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
|
N/A | |
Completed |
NCT02238704 -
Cornell University-Micronutrient Initiative Calcium Supplementation Study
|
N/A | |
Completed |
NCT01195441 -
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
|
N/A | |
Withdrawn |
NCT01179542 -
The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR
|
N/A | |
Completed |
NCT00456118 -
Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
|
||
Recruiting |
NCT00117546 -
Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia
|
Phase 4 | |
Completed |
NCT00787241 -
Platelet Count Trends in Pre-eclamptic Parturients
|
N/A |